BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17933231)

  • 1. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis.
    Chen L; Huang H; Zhang J; Zhang F; Liu Y; Xi H; Wang H; Gu Z; Song Y; Li Y; Tan K
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Sep; 21(9):961-6. PubMed ID: 17933231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.
    Huang H; Chen L; Xi H; Wang H; Zhang J; Zhang F; Liu Y
    Clin Transplant; 2008; 22(6):710-8. PubMed ID: 18673377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR spectroscopy evaluation and short-term outcome of olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients.
    Huang H; Tan K; Chen L; Xue Y; Wang H; Xi H; Liu Y; Zhang F; Zhang J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jan; 21(1):52-7. PubMed ID: 17305006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients].
    Huang H; Chen L; Xi H; Wang Q; Zhang J; Liu Y; Zhang F
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):14-20. PubMed ID: 19192871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury.
    Huang H; Chen L; Wang H; Xiu B; Li B; Wang R; Zhang J; Zhang F; Gu Z; Li Y; Song Y; Hao W; Pang S; Sun J
    Chin Med J (Engl); 2003 Oct; 116(10):1488-91. PubMed ID: 14570607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations.
    Chen L; Chen D; Xi H; Wang Q; Liu Y; Zhang F; Wang H; Ren Y; Xiao J; Wang Y; Huang H
    Cell Transplant; 2012; 21 Suppl 1():S65-77. PubMed ID: 22507682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.
    Huang H; Xi H; Chen L; Zhang F; Liu Y
    Cell Transplant; 2012; 21 Suppl 1():S23-31. PubMed ID: 22507677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS.
    Piepers S; van den Berg LH
    Amyotroph Lateral Scler; 2010 May; 11(3):328-30. PubMed ID: 20433414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on repair of subacute spinal cord injury by transplantation of olfactory ensheathing cells combined with chondroitinase ABC in adult rats].
    Zhang C; He X; Lan B; Li H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):8-13. PubMed ID: 19192870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cell transplantation protocol and its application to an ALS mouse model.
    Morita E; Watanabe Y; Ishimoto M; Nakano T; Kitayama M; Yasui K; Fukada Y; Doi K; Karunaratne A; Murrell WG; Sutharsan R; Mackay-Sim A; Hata Y; Nakashima K
    Exp Neurol; 2008 Oct; 213(2):431-8. PubMed ID: 18691571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous olfactory ensheathing cell transplantation in human spinal cord injury.
    Féron F; Perry C; Cochrane J; Licina P; Nowitzke A; Urquhart S; Geraghty T; Mackay-Sim A
    Brain; 2005 Dec; 128(Pt 12):2951-60. PubMed ID: 16219671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.
    Deda H; Inci MC; Kürekçi AE; Sav A; Kayihan K; Ozgün E; Ustünsoy GE; Kocabay S
    Cytotherapy; 2009; 11(1):18-25. PubMed ID: 19012065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transplanting olfactory ensheathing cells on recovery of olfactory epithelium after olfactory nerve transection in rats.
    Wei Y; Miao X; Xian M; Zhang C; Liu X; Zhao H; Zhan X; Han D
    Med Sci Monit; 2008 Oct; 14(10):BR198-204. PubMed ID: 18830183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of olfactory ensheathing cells transplantation on protecting spinal cord and neurons after peripheral nerve injury].
    Wang C; Shi Z; Wang K
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Nov; 19(11):875-8. PubMed ID: 16334232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis.
    Liu XX; Zhang J; Zheng JY; Zhang S; Xu YS; Kang DX; Fan DS
    Muscle Nerve; 2009 Mar; 39(3):304-9. PubMed ID: 19208412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of exogenous risk factors in amyotrophic lateral sclerosis in Wakayama, Japan.
    Kihira T; Kanno S; Miwa H; Okamoto K; Kondo T
    Amyotroph Lateral Scler; 2007 Jun; 8(3):150-6. PubMed ID: 17538776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary function tests and diaphragmatic compound muscle action potential in patients with sporadic amyotrophic lateral sclerosis.
    Sathyaprabha TN; Pradhan C; Nalini A; Thennarasu K; Raju TR
    Acta Neurol Scand; 2010 Jun; 121(6):400-5. PubMed ID: 20070278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.